荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09995 荣昌生物

已收盘 12-05 16:09:08

88.350

-1.350

-1.51%

最高91.100	最低87.350	成交量215.00万
今开89.000	昨收89.700	日振幅4.18%
总市值497.95亿	流通市值184.28亿	总股本5.64亿
成交额1.90亿	换手率1.03%	流通股本2.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":88.35,"timestamp":1764922148010,"preClose":89.7,"halted":0,"volume":2150000,"delay":0,"floatShares":208581239,"shares":563608243,"eps":-3.006766162182362,"marketStatus":"已收盘","change":-1.35,"latestTime":"12-05 16:09:08","open":89,"high":91.1,"low":87.35,"amount":189901737,"amplitude":0.041806,"askPrice":88.35,"askSize":7500,"bidPrice":88.25,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.9221330916012707,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":89.7,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.649444,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":96.45,"timestamp":1764918000000,"preClose":95.37,"halted":0,"volume":3324300,"delay":0,"premium":"-16.83"}},"requestUrl":"/m/hq/s/09995/tweets","defaultTab":"tweets","newsList":[{"id":"2588688188","title":"拜耳降价，齐鲁秒跟，却打中了绿叶制药的“七寸”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588688188","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588688188?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:41","pubTimestamp":1764848486,"startTime":"0","endTime":"0","summary":"但拜耳和齐鲁这轮降价，却正好打中了 绿叶制药 的七寸。11月26日， 绿叶制药 子公司 博安生物 的阿柏西普生物类似药获批上市，成为国内第二个获批的产品。齐鲁制药是最先成功的。2023年12月，齐鲁制药阿柏西普生物类似药获批上市。2024年8月，齐鲁拿下了雷珠单抗国内首个生物类似药。9月30日，RC28已经申报上市，用于治疗糖尿病黄斑水肿，预计不久后就将加入眼底病用药的“战场”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204194908a4cc968e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204194908a4cc968e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","01801","02186","BK1583","BK1574","LU1969619763.USD","BK1191","BK1606","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2588012889","title":"每日卖空追踪 | 荣昌生物 12月04日卖空量成交6.65万股，卖空比例为1.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588012889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588012889?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837042,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间12月04日，涨6.22%，卖空量成交6.65万股，较上一交易日增加20.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163710952a7d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163710952a7d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1583","09995","BK1574","BK1161","LU2328871848.SGD"],"gpt_icon":0},{"id":"2588074906","title":"医药股普遍回暖 荣昌生物(09995)涨4.26% 交银国际料明年内地医药板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2588074906","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588074906?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:58","pubTimestamp":1764817092,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股普遍回暖，荣昌生物 涨4.26%，康方生物涨3.89%，金斯瑞生物科技涨3.11%，康诺亚-B涨2.95%，科伦博泰生物-B涨2.45%，诺诚健华涨1.79%，药明生物涨1.63%，泰格医药涨1.38%，药明康德涨1.33% 。交银国际发表报告指，予内地医药行业领先评级。如该行此前预期，内地医药行业2025年迎来关键转折。2026年，该行认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NmI5OTlmYjAxY2FmOGFlNWZkYjg2NDM0MTE4MzUwMDcw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970883","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU0516422952.EUR","IE00BPRC5H50.USD","09926","LU0819121731.USD","03329","HK0000320264.USD","LU2399975544.HKD","LU0634319403.HKD","BK1610","LU1720050803.USD","688331","LU2242644610.SGD","LU0359201612.USD","LU0516423091.SGD","LU2148510915.USD","LU0181495838.USD","02162","BK1574","LU0823426308.USD","LU1688375341.USD","LU1961090484.USD","LU0856984785.SGD","09969","LU2039709279.SGD","BK0239","LU2488822045.USD","BK1589","LU0561508036.HKD","02269","159938","LU0052750758.USD","BK1141","LU0359202008.SGD","BK1587","09939","LU1880383366.USD","02359","06990","LU0326950275.SGD","03347","09995","BK1161","LU0307460666.USD","01548","LU2328871848.SGD","LU2476274720.SGD","LU0417516571.SGD","LU1046422090.SGD","BK1515"],"gpt_icon":0},{"id":"1111321941","title":"异动解读 | 荣昌生物盘中大涨5.09%，贝莱德增持叠加机构看好商业化能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1111321941","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111321941?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:56","pubTimestamp":1764817007,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中大涨5.09%，成为市场焦点。消息面上，根据香港联交所披露的文件，贝莱德(BlackRock, Inc.)于11月24日以每股均价82.9384港元增持461.3万股H股股份，价值约3.83亿港元，好仓比例由2.86%升至5.07%。此外，中泰证券研报指出，荣昌生物正处在商业化能力加速兑现的通道上，通过高效的运营和精准的投入，公司正快速向盈亏平衡点靠拢，并维持“增持”评级。机构增持和乐观研报共同推动了股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"1173505017","title":"异动解读 | 荣昌生物盘中大涨5.09%，贝莱德大手笔增持提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1173505017","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173505017?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:56","pubTimestamp":1764817005,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中大涨5.09%，成为市场焦点。消息面上，根据香港联交所披露的文件，贝莱德(BlackRock, Inc.)于11月24日以每股均价82.9384港元增持461.3万股H股股份，价值约3.83亿港元。增持后，贝莱德最新持股比例由2.86%升至5.07%。这一大手笔增持显著增强了市场对荣昌生物的信心。此外，中泰证券研报指出，荣昌生物正处在商业化能力加速兑现的通道上，通过高效的运营和精准的投入，公司正快速向盈亏平衡点靠拢。该机构维持“增持”评级，进一步支撑了股价的上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"2588407102","title":"荣昌生物(09995)涨逾4%终结三连阴 此前获贝莱德大手增持 机构指其正快速向盈亏平衡点靠拢","url":"https://stock-news.laohu8.com/highlight/detail?id=2588407102","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588407102?lang=zh_cn&edition=full","pubTime":"2025-12-04 10:33","pubTimestamp":1764815583,"startTime":"0","endTime":"0","summary":"金吾财讯 | 荣昌生物(09995)早盘股价反弹回升，终结此前日线图三连阴，截至发稿，报88港元，涨4.2%，成交额1.11亿港元。消息面上，根据香港联交所11月28日披露的文件，贝莱德(BlackRock, Inc.)于11月24日以每股均价82.9384港元增持461.3万股H股股份，价值约3.83亿港元。增持后，贝莱德最新持股数目为1,057.95万股股份，好仓比例由2.86%升至5.07%。中泰证券研报指，荣昌生物正处在商业化能力加速兑现的通道上，通过高效的运营和精准的投入，公司正快速向盈亏平衡点靠拢。维持“增持”评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970881","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","688331","LU0130102774.USD","LU1509826696.USD","LU2505996681.GBP","BK4534","LU1280957306.USD","BK1161","IE00BGHQF631.EUR","IE00B3QW5Z07.USD","LU0640476718.USD","IE00B42XCP33.USD","LU0772969993.USD","LU2328871848.SGD","LU2430703251.USD","LU1599440770.SGD","IE00B64PRP62.GBP","IE00BVYPNW00.USD","LU0070302665.USD","LU1481011671.HKD","LU1366333091.USD","BLK","BK4135","IE00B3PB1722.GBP","09995","LU1064130708.USD","LU1201861249.SGD","LU1064131003.USD","BK1583","LU0157215616.USD","LU2505996509.AUD","LU0731783394.SGD","BK4567","LU0980610538.SGD","BK4581","LU0320765489.SGD","LU2488822045.USD","BK4533","BK1574","LU2264538146.SGD","IE00BDGV0183.EUR","IE00BGHQF748.EUR","LU0742537680.HKD","LU0648001328.SGD","LU1670627923.USD","IE00BVYPNV92.GBP","LU1969619763.USD","BK4504","LU0208291251.USD"],"gpt_icon":0},{"id":"1184350727","title":"港股生物医药股表现活跃！心玮医疗-B涨近5%，歌礼制药-B涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184350727","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184350727?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:43","pubTimestamp":1764812582,"startTime":"0","endTime":"0","summary":"12月4日，港股$生物(000504)$医药股盘初表现活跃，$心玮医疗-B(06609)$涨近5%，$歌礼制药-B(01672)$涨超4%，$嘉和生物-B(06998)$涨近3%，$康方生物(09926)$、$荣昌生物(09995)$涨超2%>>","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"78017fe3ba4f859116cb01c02d313574","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348784397.USD","LU1794554557.SGD","LU2778985437.USD","LU0348767384.USD","09995","01672","LU0634319403.HKD","BK1587","BK1574","LU2328871848.SGD","LU0348735423.USD","LU0348827113.USD","BK1583","IE00BPRC5H50.USD","06609","LU0417516571.SGD","BK1100","LU0540923850.HKD","LU1969619763.USD","LU1961090484.USD","LU0348766576.USD","09926","01477","BK1161","IE00B543WZ88.USD","09939","BK1191","LU0417516902.SGD","LU0348825331.USD","LU0417516738.SGD","LU0561508036.HKD","LU2399975544.HKD","LU2476274720.SGD","LU2488822045.USD","06998","LU2476274308.USD","LU0348783233.USD","BK1515","LU1720050803.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2588045496","title":"核心高管精准减持“撤离”，控股股东却被“锁仓”，荣昌生物何时才能盈利？｜创新药观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2588045496","media":"华夏时报网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588045496?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:23","pubTimestamp":1764764612,"startTime":"0","endTime":"0","summary":"2025年12月3日，一则荣昌生物制药（烟台）股份有限公司（下称“荣昌生物”，股票代码688331.SH、9995.HK）疑似减持受限的消息引起《华夏时报》记者注意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512033581742820.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512033581742820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064131003.USD","BK1574","09995","BK0239","BK1161","LU1064130708.USD","LU2148510915.USD","06978","LU2328871848.SGD","LU2488822045.USD","688331","BK1583","LU1969619763.USD","159992"],"gpt_icon":0},{"id":"2588843072","title":"每日卖空追踪 | 荣昌生物 12月03日卖空量成交2.55万股，卖空比例为1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588843072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588843072?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750637,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间12月03日，跌1.46%，卖空量成交2.55万股，较上一交易日增加24.39%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163631978d7c95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163631978d7c95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1969619763.USD","LU2328871848.SGD","BK1574","BK1583","09995"],"gpt_icon":0},{"id":"2588090548","title":"【券商聚焦】中泰证券维持荣昌生物(09995)“增持”评级 指其正处在商业化能力加速兑现的通道上","url":"https://stock-news.laohu8.com/highlight/detail?id=2588090548","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588090548?lang=zh_cn&edition=full","pubTime":"2025-12-03 14:26","pubTimestamp":1764743192,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰证券研报指，荣昌生物 营业总收入17.20亿元；归母净利润-5.51亿元，亏损收窄，主要得益于核心产品的持续放量、销售和管理费用的有效控制，以及泰它西普海外临床费用转由合作方承担后带来的研发支出下降；销售毛利率84.27%，+4.52个百分点，研发费用8.91亿元。荣昌生物正处在商业化能力加速兑现的通道上，通过高效的运营和精准的投入，公司正快速向盈亏平衡点靠拢。维持“增持”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970822","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600918","09995","688331"],"gpt_icon":0},{"id":"2588960059","title":"荣昌生物（688331）披露预计2026-2028年度日常关联交易议案，12月02日股价下跌2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588960059","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588960059?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:17","pubTimestamp":1764685032,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，荣昌生物报收于93.23元，较前一交易日下跌2.11%，最新总市值为525.55亿元。该股当日开盘94.0元，最高95.97元，最低92.96元，成交额达2.55亿元，换手率为1.67%。公司近日发布公告称，荣昌生物制药（烟台）股份有限公司于2025年12月2日召开2025年第三次临时股东会，会议审议通过《关于预计2026-2028年度日常关联交易的议案》及《关于修订公司部分治理制度的议案》下的四项子议案。出席会议的股东共180人，代表表决权股份占公司总表决权的47.5817%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","BK0239","LU2328871848.SGD","LU1064131003.USD","BK1583","LU1969619763.USD","LU2148510915.USD","BK1574","LU1064130708.USD","LU2488822045.USD","688331","BK1161"],"gpt_icon":0},{"id":"2588705477","title":"每日卖空追踪 | 荣昌生物 12月01日卖空量成交11.85万股，卖空比例为2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588705477?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577840,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间12月01日，跌4.9%，卖空量成交11.85万股，较上一交易日减少66.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163630a4c552c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163630a4c552c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","09995","BK1161","BK1574","BK1583","LU1969619763.USD"],"gpt_icon":0},{"id":"2588705237","title":"荣昌生物12月01日主力净流出1077.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588705237?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576911,"startTime":"0","endTime":"0","summary":"12月01日, 荣昌生物股价跌4.90%，报收88.40元，成交金额3.6亿元，换手率1.92%，振幅8.23%，量比0.53。荣昌生物今日主力资金净流出1077.2万元，上一交易日主力净流入2556.5万元。该股近5个交易日上涨6.75%，主力资金累计净流入6535.0万元；近20日主力资金累计净流入8010.5万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161535a4c54553&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201161535a4c54553&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","LU2328871848.SGD","BK1583","BK1574","BK1161","09995"],"gpt_icon":0},{"id":"1142174655","title":"异动解读 | 荣昌生物盘中大跌5%，因遭贝莱德减持18.55万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1142174655","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142174655?lang=zh_cn&edition=full","pubTime":"2025-12-01 10:36","pubTimestamp":1764556601,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中股价大跌5%，引发市场关注。消息面上，香港联交所最新资料显示，贝莱德于11月25日减持荣昌生物18.55万股，每股作价81.6411港元，总金额约为1514.44万港元。减持后，贝莱德持股比例降至4.99%。此次减持行为可能引发了市场对荣昌生物短期走势的担忧，导致股价承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"1141463900","title":"异动解读 | 荣昌生物遭贝莱德减持18.55万股，盘中大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141463900","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141463900?lang=zh_cn&edition=full","pubTime":"2025-12-01 10:36","pubTimestamp":1764556601,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中大跌5%，市场表现疲软。消息面上，香港联交所最新资料显示，贝莱德于11月25日减持荣昌生物18.55万股，每股作价81.6411港元，总金额约为1514.44万港元。减持后，贝莱德持股比例降至4.99%。机构投资者的减持行为往往会影响市场情绪，可能导致股价短期承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"1141221356","title":"异动解读 | 荣昌生物盘中大跌5%，贝莱德减持引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1141221356","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141221356?lang=zh_cn&edition=full","pubTime":"2025-12-01 10:36","pubTimestamp":1764556600,"startTime":"0","endTime":"0","summary":"荣昌生物（09995）今日盘中大跌5%，引起了市场的广泛关注。消息面上，香港联交所最新资料显示，贝莱德于11月25日减持荣昌生物18.55万股，每股作价81.6411港元，总金额约为1514.44万港元。减持后，贝莱德的最新持股比例降至4.99%。此次减持可能引发了投资者的担忧，导致股价承压。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"1127741302","title":"异动解读 | 荣昌生物盘中大跌5%，贝莱德减持引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1127741302","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127741302?lang=zh_cn&edition=full","pubTime":"2025-12-01 10:36","pubTimestamp":1764556593,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中股价大幅下跌5%，市场表现疲软。消息面上，贝莱德(BLK)于11月25日减持荣昌生物18.55万股，每股作价约81.64港元，总金额达1514.44万港元。减持后，贝莱德持股比例降至4.99%。此次减持行为可能引发了市场对机构投资者信心的担忧，进而导致股价承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"gpt_icon":0},{"id":"2588115737","title":"荣昌生物遭贝莱德减持18.55万股 每股作价约81.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588115737","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588115737?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:51","pubTimestamp":1764550260,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，11月25日，贝莱德减持荣昌生物（09995）18.55万股，每股作价81.6411港元，总金额约为1514.44万港元。减持后最新持股数目约为1041.11万股，最新持股比例为4.99%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-12-01/doc-infzhauh5174148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0742537680.HKD","BK1574","LU1064131342.USD","IE00B42XCP33.USD","IE00BVYPNW00.USD","IE00B3PB1722.GBP","LU0157215616.USD","LU1291159041.SGD","LU2505996681.GBP","BLK","LU0640476718.USD","IE00BDGV0183.EUR","LU1366333091.USD","LU0648001328.SGD","LU1988902786.USD","LU2264538146.SGD","LU2430703095.HKD","LU2505996509.AUD","BK4588","BK0239","IE00B3QW5Z07.USD","LU0731783394.SGD","BK4135","LU2488822045.USD","LU0731783048.USD","LU0980610538.SGD","LU1481011911.USD","LU1989771016.USD","IE00B64PRP62.GBP","LU0070302665.USD","IE00BVYPNV92.GBP","BK4567","BK4585","LU1074936037.SGD","09995","LU0130102774.USD","LU1064130708.USD","LU2430703251.USD","BK1161","LU2328871848.SGD","LU1481011671.HKD","LU1969619763.USD","LU1599440770.SGD","LU2430703178.SGD","BK4581","BK1583","688331","LU1064131003.USD","LU2592432038.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2587973017","title":"智通财经港股12月投资策略及十大金股","url":"https://stock-news.laohu8.com/highlight/detail?id=2587973017","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587973017?lang=zh_cn&edition=full","pubTime":"2025-11-30 22:19","pubTimestamp":1764512382,"startTime":"0","endTime":"0","summary":"随后“鲍威尔盟友”连续发声支持降息，市场对美联储 12 月降息预期大幅升至 80%。2025 年 12 月投资策略：跟着预期走智通财经 11 月金股持续跑赢大盘。11 月同期恒指最大涨幅 5%，十大金股 11 月平均最大涨幅 11.6%。其次是 12 月一些重大事件带来的预期。大的事件层面，机器人消息比较多，宇树科技：预计 12 月底前提交 IPO 申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00552","GCmain","GDX","LU0327786744.USD","02282","BK1529","02465","159934","00788","BK1183","LU0823413587.USD","BK1148","LU0348766576.USD","MG","NUGT","SGXZ86797644.SGD","BK1198","BK1521","BK1191","BK1133","02402","LU0499858438.USD","LU0823413660.USD","LU0039217434.USD","02099","03692","06160","02238","DUST","IAU","09995","BK1161","SGUmain","LU0211977185.USD","02648","MGCmain","LU0164865239.USD","LU0499858602.USD","LU0345776255.USD","LU1481107354.HKD","SGXZ62798434.SGD","SGCmain","LU0593848301.USD","BK1172","BK4123","09863","518880"],"gpt_icon":1},{"id":"2586841784","title":"贝莱德减持荣昌生物(09995)18.55万股 每股作价约81.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586841784","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586841784?lang=zh_cn&edition=full","pubTime":"2025-11-28 20:04","pubTimestamp":1764331478,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，11月25日，贝莱德减持荣昌生物(09995)18.55万股，每股作价81.6411港元，总金额约为1514.44万港元。减持后最新持股数目约为1041.11万股，最新持股比例为4.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0731783048.USD","BK4585","LU2592432038.USD","688331","LU0130102774.USD","BK4535","LU1509826696.USD","LU2505996681.GBP","LU1280957306.USD","LU1064131342.USD","BK1161","IE00B3QW5Z07.USD","LU0640476718.USD","LU2328871848.SGD","LU0772969993.USD","LU2430703251.USD","LU1599440770.SGD","IE00B64PRP62.GBP","IE00BVYPNW00.USD","LU1989771016.USD","LU0070302665.USD","BLK","BK4135","IE00B3PB1722.GBP","09995","LU1201861249.SGD","LU1988902786.USD","LU1064131003.USD","LU2505996509.AUD","LU2430703178.SGD","LU1074936037.SGD","LU0731783394.SGD","LU1670628061.USD","LU2148510915.USD","BK4567","LU0980610538.SGD","LU0320765489.SGD","BK4533","LU1291159041.SGD","BK1574","LU2264538146.SGD","IE00BDGV0183.EUR","IE00BGHQF748.EUR","LU0742537680.HKD","LU0648001328.SGD","LU1670627923.USD","IE00BVYPNV92.GBP","LU1969619763.USD","BK4504","LU0208291251.USD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0143},{"period":"3month","weight":-0.0297},{"period":"6month","weight":0.95},{"period":"1year","weight":4.1375},{"period":"ytd","weight":5.2292}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.166095},{"month":2,"riseRate":0.8,"avgChangeRate":0.209338},{"month":3,"riseRate":0.4,"avgChangeRate":-0.022811},{"month":4,"riseRate":0.8,"avgChangeRate":0.104301},{"month":5,"riseRate":0.4,"avgChangeRate":-0.023394},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.02173}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}